F2G has raised $100 million to advance its lead antifungal drug, olorofim, despite a setback with the FDA requesting further ...

Japanese biopharma firm PeptiDream says that its wholly-owned PDRadiopharma subsidiary has entered into a strategic ...

The US FDA has granted Kite’s Yescarta (axicabtagene ciloleucel) a Regenerative Medicine Advanced Therapy (RMAT) designation ...

Teva Pharmaceutical and mAbxience have signed a second global licensing deal to develop an anti PD-1 oncology biosimilar. The ...

US clinical-stage biotech Arcus Biosciences has entered into a clinical trial collaboration with AstraZeneca on renal cancer ...

Kedrion Biopharma has finalized a long-term agreement with Biotest, now part of Grifols, to commercialize and distribute ...

The US Food and Drug Administration (FDA) has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 ...

Caliway Biopharmaceuticals raised NT$6.4 billion ($206 million) in Taiwan’s largest biotech IPO, positioning the company at a ...

Ferring Pharmaceuticals has opened a global manufacturing hub in Finland to produce the drug substance for Adstiladrin, its ...

French drug developer Abivax today announced the results of an interim efficacy and safety analysis of an open-label ...

AstraZeneca's supplemental New Drug Application for Calquence (acalabrutinib) has been granted Priority Review by the US FDA ...

US clinical-stage biotech Spyre Therapeutics says it has appointed of Sheldon Sloan as its chief medical officer (CMO).